![](/img/cover-not-exists.png)
Patients homozygous forDPYDc.1129-5923C>G/haplotype B3 have partial DPD deficiency and require a dose reduction when treated with fluoropyrimidines
Meulendijks, Didier, Henricks, Linda M., van Kuilenburg, André B. P., Jacobs, Bart A. W., Aliev, Abidin, Rozeman, Lisette, Meijer, Judith, Beijnen, Jos H., de Graaf, Hiltje, Cats, Annemieke, SchellensVolume:
78
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-016-3137-0
Date:
October, 2016
File:
PDF, 465 KB
english, 2016